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Abstract
Background: Autopsy rates in Western countries consistently decline to an average of ,5%, although clinical autopsies
represent a reasonable tool for quality control in hospitals, medically and economically. Comparing pre- and postmortal
diagnoses, diagnostic discrepancies as uncovered by clinical autopsies supply crucial information on how to improve clinical
treatment. The study aimed at analyzing current diagnostic discrepancy rates, investigating their influencing factors and
identifying risk profiles of patients that could be affected by a diagnostic discrepancy.
Methods and Findings: Of all adult autopsy cases of the Charite ´ Institute of Pathology from the years 1988, 1993, 1998,
2003 and 2008, the pre- and postmortal diagnoses and all demographic data were analyzed retrospectively. Based on power
analysis, 1,800 cases were randomly selected to perform discrepancy classification (class I-VI) according to modified
Goldman criteria. The rate of discrepancies in major diagnoses (class I) was 10.7% (95% CI: 7.7%–14.7%) in 2008 representing
a reduction by 15.1%. Subgroup analysis revealed several influencing factors to significantly correlate with the discrepancy
rate. Cardiovascular diseases had the highest frequency among class-I-discrepancies. Comparing the 1988-data of East- and
West-Berlin, no significant differences were found in diagnostic discrepancies despite an autopsy rate differing by nearly
50%. A risk profile analysis visualized by intuitive heatmaps revealed a significantly high discrepancy rate in patients treated
in low or intermediate care units at community hospitals. In this collective, patients with genitourinary/renal or infectious
diseases were at particularly high risk.
Conclusions: This is the current largest and most comprehensive study on diagnostic discrepancies worldwide. Our well-
powered analysis revealed a significant rate of class-I-discrepancies indicating that autopsies are still of value. The identified
risk profiles may aid both pathologists and clinicians to identify patients at increased risk for a discrepant diagnosis and
possibly suboptimal treatment intra vitam.
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Introduction
Although clinical non-forensic autopsies are periodically con-
sidered by both clinicians and pathologists to be of high value [1–
3] and are even supported by the vast majority of the population
[4,5], autopsy rates in the USA and in Europe have consistently
declined during the last decades: from about 60% in the USA in
the 1950’s to ,5% in the first years of the 21
st century [6,7].
Consistently, a representative poll of the German National
Professional Organisation of Pathologists (Berufsverband
Deutscher Pathologen) estimated an autopsy rate of approximately
3.5% in Germany for 2004 [8]. The reasons are manifold and
comprise, amongst others, financial interests/reimbursement
policy, political disinterests, concerns over litigation and deficient
communication between clinicians, relatives and pathologists,
respectively as well as the often privately quoted notion that there
is no demand for clinical autopsies due to improved diagnostic
techniques rendering autopsies redundant [7,9–11]. However, it is
well known that causes of death ascertained by the attending
clinicians disagree in a considerable rate with the pathological
findings in clinical autopsies [2,12–15]. Two studies comparing
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improvement in diagnostic concordance over time [16,17].
A study initiated by the U.S. Department of Health and Human
Services in 2002 evaluated more than 30,000 entries from Medline
and Cochrane literature searches and concluded that only 25% of
the causes of death statements in death certificates are correct and
clinicians are not able to predict which autopsies will be of high
diagnostic yield [18]. Moreover, the major discrepancy rate
between clinical and pathological diagnoses was 35.4%. The
German Medical Association (Bundesa ¨rztekammer) published a
similar paper in 2005 drawing comparable conclusions [19].
In this context, it is suggested that clinical autopsies are a
reliable and economically reasonable quality control measure in
hospitals [20–23].
However, recent comprehensive data from a large European
patient cohort encompassing both university and community
hospitals are lacking. Hence, we set out to investigate the rate and
significance of major and minor diagnostic discrepancies between
clinical and autopsy diagnoses in 1,800 randomly selected adult
patients treated at the Charite ´ University Hospital Berlin and at
community hospitals in Berlin and Brandenburg over three
decades from 1988 to 2008. These data were correlated with
various parameters including patient demographics, disease
groups, hospital type, clinical subspecialty and type of ward.
In addition to evaluating the accuracy of clinical diagnoses with
respect to autopsy results, our analysis also allowed us to deduce
diagnosis-specific discrepancy statistics. From these results risk
profiles can be derived that may help to identify patients with a
higher probability to receive a discrepant major diagnosis intra
vitam. These data may also help to define a subgroup of patients,
for which the autopsy will particularly contribute to an improved
understanding of the clinical course of the patient including the
circumstances of death.
Moreover, our study also aims to shed light on the influence of
two different health care systems at the very end of the cold war by
comparing the discrepancy rate in university and community
hospitals of and around East and West Berlin in 1988 – one year
prior to the fall of the Berlin wall.
Methods
Ethics Statement
This register-based research study of pre-existing personal data
has been approved by the Ethical Committee of the Charite ´
University Hospital Berlin, Germany and meets the German legal
requirements concerning human subjects (Application No.:E A4/
1071/11).
Data Acquisition and Analysis of Autopsy Reports
Excluding neonates, children and adolescents (until the age of
18), each autopsy case of the Institute of Pathology of the Charite ´
University Medicine (Campus Charite ´ Mitte (CCM) and Campus
Virchow Hospital (CVK)), Berlin, Germany, from 1988, 1993,
1998, 2003 and 2008 was analyzed retrospectively with permission
of the local ethics committee (Application No.:E A4/1071/11).
From these 3,299 cases, all clinical and pathologic-anatomical
diagnoses were recorded as well as the cause of death, age, sex,
and the location of the last treatment (table 1) including the type of
hospital (university or community hospitals), clinical subspeciality
and type of ward (intensive care unit (ICU) and low and
intermediate care unit (LAICU)).
The Charite ´ University Medicine Berlin is a joint institution of
the Humboldt University Berlin and Free University Berlin and
comprises tertiary care hospitals at several locations (campi) within
the city. Due to the diagnostic responsibilities of the Institute of
Pathology that covered the campi CCM and CVK at the time
point when the study was launched, cases from these two campi
were included.
Community hospitals are defined as primary and secondary
care facilities. They are located in the area of Berlin/Brandenburg
and do not directly belong to the Charite ´ University Hospital. For
the period investigated, 28 different community hospitals in the
Berlin districts Charlottenburg-Wilmersdorf, Mitte, Pankow,
Reinickendorf, Spandau, Steglitz-Zehlendorf, Treptow-Ko ¨penick
as well as 8 cities of the adjacent Federal State of Brandenburg
were included.
Clinical diagnoses were those listed by the clinician on the
autopsy request form. The latter requires the clinician to give both,
a brief present and past medical history and a clinically estimated
causal sequence of death (e.g. deep vein thrombosis pulmonary
thrombembolism acute right heart failure). Pathological
diagnoses were those listed on the final autopsy report. All cases
investigated comprise patients who underwent a complete
pathological autopsy, including histological assessment of all major
internal organs. Autopsies were performed by at least one
experienced in-house pathologists from the Campus Charite ´ Mitte
(CCM; in 1993, 1998, 2003 and 2008 also supplying the CVK) or
the Campus Virchow Hospital (CVK; in 1988 still part of the Free
University, Berlin-West). Each autopsy case was both macroscop-
ically and microscopically reviewed by a consultant (=senior
pathologist) of the same institution. Pathological diagnoses were
grouped into seven disease groups according to the International
Classification of Diseases, 10th edition (ICD-10): Certain Infec-
tious and parasitic diseases (A00–B99, INF), neoplasms (C00–D48,
NP), diseases of the circulatory system (I00–I99, CV), diseases of
the respiratory system (J00–J99, PU), diseases of the digestive
system (K00–K93, GI), diseases of the genitourinary/renal system
(N00–N99, RE) and miscellaneous (remaining diagnoses, MISC).
Sample Size Calculation
A sample size calculation was carried out in order to estimate
the number of patients that are needed to detect significant
changes in diagnostic discrepancies. Two different kinds of
objectives were taken into account: First, detection of linear
changes in a time series (1988 to 2008) and, second, detection of
changes between two groups of patients. Monte-Carlo simulations
were executed in order to estimate the power of the test for an
increasing sample size. In short, for a fixed number of samples,
10,000 distributions of proportions were drawn from the binomial
distribution. The test was executed for each of the distributions
and the power was estimated by counting the number of
significant tests. This procedure was repeated for increasing
numbers of samples until the power we aimed at was reached.
It is expected that the diagnostic accuracy improved between
1988 and 2008 and led to a substantial decrease of discrepancy
rates during these years. Hence, the study was powered high
enough to detect a 2.5% decrease per year resulting in the
following sample size estimation: The number of patients that is
needed to detect a linear tend of 40%, 37.5%, 35%, 32.5%, 30%
in a time series 1988, 1993, 1998, 2003, 2008 with significance
equals to 0.05 and power equals to 0.8 is n=287 for each year.
This number of samples will yield even higher power for time
series with decrement 2.5% that start at a lower percentage, e.g.
for the series 25%, 22.5%, 20%, 17.5%, 15% (in this case the
number of samples needed is n=199 for each year).
Additionally, we aimed at comparing the discrepancy rates
between subgroups of patients, for instance, patients with diseases
of group A (e.g. cardiovascular diseases) and patients with diseases
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hospitals and patients treated in community hospitals. For this
purpose, we demanded the study to be powered highly enough to
detect a 10% change in discrepancy rates between two subgroups
of patients and obtained the following sample size estimation: The
number of patients needed to distinguish between 55% and 45%
in discrepancy in two patient groups with significance 0.05 and
power 0.8 is n=407 for each of the groups. This number of
samples will yield even higher power to distinguish between other
differences like 45% and 35%, 35% and 25%, 25% and 15%, 10%
and 5% and so on. To attain the necessary number of 407 patients
for subgroup comparison, patients were pooled, e.g. over the years
1993–2008 after the German reunification.
Randomization and Classification of Discrepancy Classes
Based on the sample size calculations, from a total of 3,299
reviewed autopsied patients, 300 cases were randomly selected for
each of the years 1993, 1998, 2003 and 2008. For 1988, 600
autopsy cases were randomized comprising East Berlin (n=300;
Institute of Pathology, CCM) and West Berlin (n=300; Institute of
Pathology, CVK; at that time part of the Free University, West
Berlin).
Subsequently,allrandomizedcases(n=1,800)wereassessedwith
regardtodiscrepanciesbetweenclinicalandpathologicaldiagnoses.
Discrepancies were graduated into six different classes according to
the modified Goldman criteria [2,13,16] (table 2). In brief, a major
discrepancy was assigned when the discrepancy in a diagnosis was
related to the cause of death (class I and II). Minor discrepancies
comprise discrepancies in diagnoses with no direct relation to cause
of death (class III and IV). Cases were assigned to the class with the
most severe discrepancy. Cases without discrepant diagnoses were
grouped into class V and non-classifiable cases (due to i.e. missing
data or medicolegal background) were designated as class VI.
Discrepancies were classified by two pathologists (DW and AS)
with ample autopsy experience. In cases of no agreement, a senior
pathologist (HJS, AE, CD or WW) was consulted. Additionally,
clinically unclear and difficult cases were analyzed by a board-
certified physician from the Department of General, Visceral and
Transplantation Surgery, Berlin, Germany (CK).
As result, each case was assigned unambiguously to one of the
classes I–VI.
Statistical Analysis
Data analysis was performed using the statistical language R.
Statistical significance of 262 tables was assessed by Fisher’s exact
test. Significance of a trend in time series was assessed by the
Cochran-Armitage test as it is implemented by function prop.-
trend.test() in the R package stats.
In order to identify factors for a high risk of discrepancy, we
have combined an extensive subgroup analysis with heatmap
visualization. To exclude statistical bias due to different health care
systems, we considered the data of the 1,200 cases that were
Table 1. Clinical information and meta data about autopsy patients from 1988 to 2008.
Characteristics 1988 (GDR) 1988 (FRG) 1993 1998 2003 2008 Total
General Data all study all study all study all study all study all study all study
n (pat.) 1198 300 305 300 387 300 537 300 482 300 390 300 3299 1800
male [%] 55.0 58.0 40.7 40.7 55.8 56.7 57.2 57.3 62.4 61.3 59.0 60.3 55.7 55.7
female [%] 45.0 42.0 59.3 59.3 44.2 43.3 42.8 42.7 37.6 38.7 41.0 39.7 44.3 44.3
age (mean/median) 61.6
62.0
62.2
62.5
72.8
76.0
72.8
76.0
61.1
62.0
61.5
62.0
63.6
65.0
63.2
64.0
62.3
64.0
62.8
64.5
63.7
66.0
63.8
65.0
63.3
64.0
64.4
66.0
Autopsy rates
university hospitals [%] 96.6 44.5 22.0 22.2 26.2 20.1
community hospitals [%] 77.0 19.6 11.7 6.3 6.2 5.3
Location of last treatment (gross)
university hospitals [%] 45.9 43.6 58.0 58.7 62.3 62.0 56.7 56.5 68.7 67.0 61.5 62.0 55.9 58.3
community hospitals [%] 54.1 56.4 41.6 41.3 37.7 38.0 43.3 43.5 31.3 33.0 38.4 38.0 44.1 41.7
intensive care unit [%] 24.2 25.0 3.6 3.7 32.0 33.3 35.8 33.3 39.8 40.0 65.9 66.7 36.2 33.7
low and intermediate care unit [%] 72.9 70.7 0.3 0.3 66.9 65.7 60.5 62.3 60.0 59.7 34.1 33.3 63.8 48.7
Location of last treatment (detailed)
(internal) medicine [%] 47.3 41.7 58.7 58.7 55.8 53.7 43.0 43.3 50.4 50.3 44.9 45.3 48.8 48.8
surgery (incl. cardiac, neurol., bone) [%] 18.3 21.3 19.3 19.3 11.4 11.3 27.0 26.7 28.4 28.7 35.4 35.7 22.5 23.8
anaesthesiology [%] 13.4 12.3 1.0 1.0 19.6 21.3 16.0 14.0 8.9 10.3 14.4 13.7 12.9 12.1
neurology [%] 3.3 2.7 0.7 0.7 4.4 4.3 3.5 4.7 2.3 1.7 3.8 3.7 3.1 2.9
other [%] 16.7 20.3 18.7 18.7 8.0 8.3 6.3 6.7 10.0 9.0 1.3 1.3 11.4 10.7
unknown [%] 1.1 1.7 1.6 1.7 0.8 1.0 4.1 4.7 0.0 0.0 0.3 0.3 1.3 1.6
The data presented here do not reveal significant differences between ‘‘all’’ and ‘‘study’’ group concerning the distribution of the characteristics considered, therefore
representativeness can be assumed.
doi:10.1371/journal.pone.0037460.t001
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patients were grouped according to demographics or the ward
where they were treated. This grouping was intersected with a
second grouping according to disease groups. For each of the
subgroups, the percentage of discrepancies was calculated and
compared to the percentage of discrepancies for patients not in the
subgroup. Significance of a decreased or increased discrepancy
risk was assessed by Fisher’s exact test.
In general, significance assessments were based on two-sided p-
values. P-values ,0.05 were considered as significant, p-values
,0.1 as borderline significant.
Results
Analysis of the Autopsy Patient Meta Data
A total of 3,299 autopsy cases of the Charite ´ Institute of
Pathology between 1988 and 2008 were recorded (table 1, referred
to as ‘‘all’’ groups). With the exception of the year 1988 (West
Berlin), between 1988 and 2008 more autopsies were performed
on men than on women (1.3 :1). In university hospitals the autopsy
rate remained nearly constant at a mean value of about 23%
between 1993 and 2008. Before reunification in 1988, the autopsy
rate was considerably higher in East (96.6%) versus West Berlin
(44.5%). A similar trend was seen for the autopsy rates of
community hospitals where the autopsy rate decreased from
77.0% (GDR [German Democratic Republic], 1988) and 19.6%
(FRG [Federal Republic of Germany], 1988) to a constantly low
rate of about 6% (1998 to 2008). The proportion of autopsied
patients from university hospitals continuously increased from
45.7% (1988) to 87.2% (2008) in the course of time, whereas the
correspondent proportion of autopsies requested by community
hospitals declined from 54.0% (1988) to 12.8% (2008). Notewor-
thy, the proportion of autopsied patients under intensive care
before death strongly increased over time from 24.2% (1988) to
65.9% (2008). Similar results were found for the study population,
which showed an increase of ICU cases from 25.0% (1988) to
66.7% in 2008. Autopsies of patients from low and intermediate
care units (LAICUs), however, declined from 72.9% (1988) to
34.1% (2008). During the time period investigated, patients were
most commonly treated on a ward of (internal) medicine, followed
by surgical wards. Cardiovascular diseases were the most frequent
diagnoses according to autopsy, followed by neoplastic and
pulmonary diseases (table 3, ‘‘all’’ groups). With respect to the
cause of death, cardiovascular diseases ranked first, followed by
neoplastic diseases (table 3, ‘‘c.o.d.’’).
Assessment of Discrepancy Rates by Means of Modified
Goldman Criteria
Comparison of the study population with the total cohort
(referred to as ‘‘study’’ and ‘‘all’’, respectively, see table 1 and 3),
reveals that the 1,800 randomly selected cases were representative
for the total cohort of 3,299 autopsy cases.
The randomized cases were assigned to classes I to VI according
to the modified Goldman criteria (table 2). Figure 1a shows the
country and time dependent distribution of the discrepancy
classes. Herein, the proportion of class I discrepancies significantly
declined by 15.1% from 25.8% (1988) to 10.7% (2008)
(p,0.00001, 95% CI: 7.7%–14.7%). The proportion of class III
discrepancies increased from 13.7% (1988) to 27.0% (2008)
(p,0.00001). There was no significant change in the proportions
of class II and class IV discrepancies. The largest group comprised
the cases without discrepancies (49.1%, class V), whereas only a
small number of cases (4.1%, class VI) were non-classifiable.
The temporal development of the total major discrepancy rate
(class I and II) reveals a significant decline by 16.3% from 43.4%
(1988) to 27.1% (2008) (figure 1b, p,0.00001). Minor discrepan-
cies (class III and IV) increased from 16.4% (1988) to 33.0% (2008)
(p,0.00001).
Investigation of Factors Possibly Influencing the Class I
Discrepancy Rate
1.) Sex and Age. Class I discrepancies of female patients
significantly decreased from 31.4% (1988) to 10.5% (2008)
(figure 2a, p,0.00001). The decrease of class I discrepancies of
male patients from 22.0% (1988) to 11.5% (2008) was also
significant (p=0.0097).
In 1988, the class I discrepancy rate of female patients was
31.4% compared to 22.0% for male patients (borderline signifi-
cant, p=0.057). From 1993 to 2008 the class I discrepancy rate
did not significantly differ between male and female patients.
Class I discrepancies of female patients significantly increased
with age (p=0.00014), whereas no significant change was
observed for male patients (p=0.19; figure 2b).
2.) Type of hospital. From 1988 to 2008 the class I
discrepancy rate was significantly higher in community hospitals
than in university hospitals (p=0.045) (figure 3a). In university
Table 2. Criteria for evaluating discrepancies modified after Goldman et al. (1983) and Battle et al. (1987).
major discrepancies class I discrepancies in major diagnoses with relation to cause of death
detection would have led to changes in management and therapy
detection and adjusted therapy could have prolonged survival or cured the patient
class II discrepancies in major diagnoses with relation to cause of death
detection would have led to changes in management and therapy
detection and adjusted therapy would not have prolonged survival or cured the patient
minor discrepancies class III discrepancies in minor diagnoses with no direct relation to cause of death
Symptoms should have been treated or would have eventually affected prognosis
class IV discrepancies in minor diagnoses with no direct relation to cause of death
Non-diagnosable (occult) diseases with possible genetic or epidemiological importance
other class V no discrepancies
class VI non-classifiable cases
doi:10.1371/journal.pone.0037460.t002
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(p=0.00071). In particular, in 2008 university hospitals (5.4%
class I discrepancies) significantly outperformed the community
hospitals (14.7% class I discrepancies, p=0.0082).
3.) Type of ward. The class I discrepancy rate of both
patients from ICUs and from LAICUs significantly declined from
1988 to 2008 (p=0.00007, p=0.00083; figure 3b). No significant
difference was found in comparing the rates against each other.
4.) Clinical subspecialty. Internal, surgical, anaesthesiolo-
gical and neurological wards initiated the vast majority of
autopsies in Berlin between 1988 and 2008 (table 1).
Of these (figure S1), internal (p=0.001), surgical (p=0.00042),
and anaesthesiological wards (p=0.015) showed a significant
improvement of the class I discrepancy rate over the years
investigated. Neurological wards, however, kept their class I
discrepancy rate nearly constant (p=0.41).
5.) Disease group (according to ICD-10). For each of the
disease groups we calculated the proportion of class I discrepancies
in relation to the total number of patients within a disease
subgroup. We observed that cardiovascular, neoplastic, pulmonary
and gastrointestinal diseased patients showed a significant decline
in class I discrepancies of their respective disease group over time
(figure S2 a,b,c,d,), e.g. among cardiovascular diseased patients a
decrease of class I discrepancies from 26.9% in 1988 to 11.8% in
2008 (p=0.00032). Regarding the other disease groups, no
significant trend was found in changes of the class I discrepancy
rates over time (data not shown).
Next, we calculated the proportion of the patients with a class I
discrepancy in relation to the total number of patients dying from
a disease group. Only cardiovascular causes of death showed a
significant decline in class I discrepancies of their respective disease
group over time (figure S3 a), whereas in the other disease groups
the causes of death revealed no significant trend over time (figure
S3 b,c,d and data not shown).
Table 3. Distribution of pathological diagnoses at autopsy.
1988 (GDR) 1988 (FRG) 1993 1998 2003 2008 Total
all studyc.o.d. all studyc.o.d. all studyc.o.d. all studyc.o.d. all studyc.o.d. all studyc.o.d. all studyc.o.d.
n (pat.) =100% 1198 300 300 305 300 300 387 300 300 537 300 300 482 300 300 390 300 300 3299 1800 1800
CV [%] 61.0 61.3 39.7 93.1 93.0 42.3 60.5 60.0 40.7 83.8 82.3 42.3 90.5 92.7 43.3 85.6 85.7 46.3 74.8 79.2 42.4
NP [%] 45.3 45.3 31.3 31.5 31.7 20.3 35.9 34.7 24.3 41.7 42.7 28.0 36.5 34.3 23.0 33.6 32.0 15.0 39.7 36.8 23.7
PU [%] 28.4 29.3 0.3 58.0 58.0 0.0 22.2 23.0 0.0 36.5 36.7 0.0 38.8 39.7 0.0 40.0 40.3 0.0 34.6 37.8 0.1
RE [%] 6.4 7.3 1.0 18.4 18.7 4.0 4.7 5.3 1.3 3.9 4.3 0.3 6.6 7.0 0.0 7.4 7.7 0.0 7.1 8.4 1.1
INF [%] 2.8 3.7 2.3 5.6 5.7 3.0 5.2 6.0 3.0 9.5 12.0 8.0 12.3 13.6 10.3 7.9 9.7 8.0 6.4 8.5 5.8
GI [%] 22.0 21.7 9.7 35.4 35.0 6.0 28.7 29.0 15.7 20.3 18.7 5.0 24.7 25.7 6.0 30.5 33.0 8.7 25.2 27.2 8.5
MISC [%] 25.0 21.7 0.7 51.1 51.7 1.3 27.7 27.3 1.7 30.5 30.3 2.0 27.2 27.0 3.0 29.2 30.0 8.0 29.4 31.3 2.8
‘‘All’’ comprises the total number of cases investigated from the respective year. The ‘‘study’’ group of a year relates to the cohort randomly selected from the ‘‘all’’
group in order to determine the discrepancy rate. The data presented here do not reveal significant differences between ‘‘all’’ and ‘‘study’’ group concerning the
distribution of post-mortem diagnoses, therefore representativeness can be assumed. ‘‘c.o.d.’’ shows the distribution of causes of death of the ‘‘study’’ group with
regard to the disease groups considered.
Disease groups according to ICD-10: CV – cardiovascular, NP – neoplastic, PU – pulmonary, RE – renal/genitourinary, INF – infectious, GI – gastrointestinal, MISC –
miscellaneous.
doi:10.1371/journal.pone.0037460.t003
Figure 1. Development of the discrepancies between clinical and pathological diagnoses at the Charite ´ hospital during the last
20 years. 300 cases were included into the analysis for each of the years 1988 (GDR), 1988 (FRG), 1993, 1998, 2003 and 2008. Cases were assigned to
discrepancy classes I to VI according to the modified Goldman criteria. a) Country and time dependent distribution of the discrepancy classes I–VI. b)
Significant decrease of major discrepancies and significant increase of minor discrepancies between 1988 and 2008. 1988= pooled GDR and FRG
cases.
doi:10.1371/journal.pone.0037460.g001
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Discrepant Major Diagnosis (Class I)
In order to identify cases with increased risk for class I
discrepancies, heatmaps of discrepancy rates were generated
(figure 4a,b). The overall class I discrepancy rate of 19.5%
[17.4%–21.9%] for 1,200 cases (black) served as reference.
As shown in the last column of figure 4b, we generally detected
significantly increased class I discrepancy rates in patients treated
at community hospitals on a low and intermediate care unit
(LAICU). For this particular patient collective, most class I
discrepancies were found in cases with genitourinary/renal
(53.8%, p=0.033) or infectious (47.4%, p=0.033) diseases.
Furthermore, female patients under the age of 65 with an
infectious disease (47.1%, p=0.05) showed a borderline-significant
increase in the class I discrepancy rate.
The significantly lowest class I discrepancy rate was found in
cases from university hospitals, treated at a LAICU and diagnosed
with a gastrointestinal disease (10.0%, p=0.031).
Comparison of Discrepancies in East and West Berlin in
1988
No statistical significant differences were found for the class I
discrepancy rate comparing the total study groups of East (n=300)
and West Berlin (n=300) data in 1988 (figure 1a, 30.2% versus
23.4%, p.0.1).
Subgroup analyses regarding sex, age, type of hospital, clinical
subspecialty and disease groups were performed in order to
compare the class I discrepancy rates in East and West Berlin in
1988. Concerning sex and age no statistically significant differ-
ences between East and West were found. Likewise, the
comparison of class I discrepancy rates did not show any
significant differences with respect to the type of hospital as well
as to the clinical subspecialty. Furthermore, subgroup analyses of
the disease groups did not reveal significantly different class I
discrepancy rates between East and West Berlin.
The same results with no statistical differences regarding the
total groups and the subgroup analyses were found for the major
discrepancy rate (class I and II combined) (54.2% versus 59.1%,
p.0.1).
Discussion
This well-powered retrospective autopsy study comprising the
largest current case series from both community and university
hospitals reveals a reduction over time in the frequency of major
discrepancies. This held particularly true for class I discrepancies
between clinical and autopsy diagnoses. Our results based on
1,800 cases of three medical decades in East and West Berlin are
Figure 2. The influence of age and sex. a) Class I discrepancy rates for male and female patients. b) Dependence of the class I discrepancy rates
on age and sex of the patients. All 1800 ‘‘study’’ cases (1988–2008) were included into the analysis.
doi:10.1371/journal.pone.0037460.g002
Figure 3. Influence of type of hospital and type of ward. a) Class I discrepancy rates for university and community hospitals. b) Class I
discrepancy rates rates for ICU’s and LAICU’s.
doi:10.1371/journal.pone.0037460.g003
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and a meta-analysis also conducted by Shojania et al. in 2003 [3].
Shojania et al. (2002) reported class I and class II discrepancies of
10.2% and 25.2%, respectively in a study initiated by the US
Department of Health and Human Services that evaluated
approximately 35,000 literature entries in Medline and Cochrane
data base. Analyzing 53 autopsy studies from 1966–2002,
Shojania and colleagues (2003) found a range for major
discrepancies from 4.1% to 49.8% (median 23.5%) and class I
discrepancies ranging from 0 to 20.7% (median 9.0%), respec-
tively.
This is in line with our data data, which show only slightly
higher discrepancies (in 2008 10.7% for class I discrepancies and
27.1% for combined major discrepancies (median values) and a
comparable relative reduction by 15.1% for class I discrepancies
from 1988 to 2008. The strong decline of major discrepancies over
the last decades, however, is consistent with recent data and
disagrees with other studies [16,17] reporting no decrease in
discrepancies over time.
The slightly higher frequency of class I and II discrepancies in
our study may be explained on the one hand by the fact that
clinical information was, as in many other studies [15,16,24–26],
solely based on the data on the autopsy request form and not on an
extensive medical chart review (as conducted by Sonderegger-Iseli
et al. 2000 [2]) thereby possibly slightly overestimating the rate of
major discrepancies due to a potential loss of clinical information
in single cases. However, this does not imply that the clinical data
actually given on the request form, which include a rather
comprehensive past and present medical history for every case as
well as the causal sequence of death, are of limited validity or
reliability.
On the other hand it is also agreed [2,16] that the definition of
the respective discrepancy classes does not always allow for a clear-
cut assignment of the cases since diseases and its influence
regarding the outcome of the patient are, especially in multi-
morbid patients, rather continuous and interconnected than
distinct. Last but not least, it has been argued that case selection
leads to a certain bias since many autopsies are requested for cases
with a particularly complex clinical picture often causing a
diagnostic and therapeutic dilemma in which discrepancies are
more likely to be observed. An intervention study could indeed
show that an incremental increase in the overall autopsy rate, and
thereby relatively decreasing the number of complex cases,
markedly reduced the proportion of discrepant cases [24].
However, data on that issue are ambiguous. For example,
Shojania and colleagues [27] argue that low autopsy rates without
adjustment for the prevalence of non-autopsied deaths may even
cause overestimation of the performance of ante-mortem clinical
diagnoses.
We also observed a clear decrease in autopsy rates for both,
university and community hospitals in the area of Berlin/
Brandenburg.
Our study reveals a statistically significant increase in minor
discrepancies corroborating the observations made by Sonder-
egger-Iseli and colleagues [2]. On the one hand, this may be due
to an actual rise in minor diagnostic discrepancies. On the other
Figure 4. Identification of low and high risks case characteristics for class I discrepancies based on a two-dimensional subgroup
analysis. Patients were grouped according to demographics or the ward where they were treated. This grouping was intersected with a second
grouping according to disease groups. For each of the subgroups, the percentage of discrepancies was calculated and compared to the percentage
of discrepancies for patients not in the subgroup. Heatmaps of discrepancy rates were generated using hierarchical clustering based on the euclidean
distance of rate profiles. The overall class I discrepancy rate of 19.5% [17.4%–21.9%] for 1200 cases (black) between 1993 and 2008 served as
reference for decreased (green) or increased (red) class I discrepancy rates. a) Dependence of class I discrepancy rates on ICD-10 disease groups, age
and sex of the patients. Sample sizes were comparable for patients being under 65 years (n=615) and patients older than 65 (n=585). b)
Dependence of class I discrepancy rates on ICD-10 disease groups, type of hospital and type of ward. x = p,0.05 (x) = p,0.1.
doi:10.1371/journal.pone.0037460.g004
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may be more carefully recorded by pathologists, thus leading to a
certain bias.
Although we could not observe a significant correlation between
sex and class I discrepancies, sex adjusted analysis, however,
revealed a positive correlation of age and the frequency of class I
discrepancies in female patients. These data match those described
in the study of Battle et al. (1987) [13], who found a significantly
higher proportion of major discrepancies in women than in men
and demonstrated increasing age-dependent rates for major
discrepancies.
Our study design also allowed us to determine the discrepancy
rate in both community and university hospitals and revealed a
significantly higher discrepancy rate for patients treated at
community hospitals. Although this is in good agreement with
the data from numerous other studies [12,13,28,29], it has to be
emphasized that in our opinion especially these autopsy cases
appeared to be those with complex and multimorbid clinical
pictures. Furthermore, we found the autopsy rates in community
hospitals always to be lower than those in university hospitals (see
table 1). Interestingly, Stevanovic and colleagues (1986) [12]
described a highly significant increase of the class I discrepancy
rate at Belgrade University Hospital in relation to an acute decline
of the autopsy rate. Hence, as already discussed, low autopsy rates
may lead to a selection bias of clinically problematic and
complicated cases, which in turn increases the class I discrepancy
rate of the community hospitals. Another important aspect was
brought up by Battle and colleagues (1987) [13] who argued that
community hospitals may often include a disproportionate number
of elderly patients, which contributes to a disproportionately high
class I discrepancy rate. Interestingly, we observed an increased
median age of patients in community hospitals compared to
university hospitals, which converge over time: 68 yrs (East Berlin
1988), vs. 55.5 yrs, 83 yrs (West Berlin 1988), vs 69 yrs, 64.5 yrs
(1993) vs. 59 yrs, 66 yrs (1998) vs. 63 yrs, 63 yrs vs. 65 yrs (2003)
and 67 yrs vs. 65 yrs (2008).
One may also pose the question, whether inherent infrastruc-
tural constraints, such as the limited availability of diagnostic or
interventional facilities as well as a lack of certain specialities for
consultative examinations, e.g. department of infectious diseases,
may also account for the higher class I discrepancy rate at least in
some of the community hospitals. The current economic strains in
the health care system leading to limited financial and/or
personnel resources may further aggravate these conditions.
Although some studies that focused on adult ICUs report a
comparably higher rate of class I discrepancies [3], we did not
observe a statistically significant difference regarding class I
discrepancies between patients treated in the ICU and LAICU,
respectively. We attribute this finding to the extensive diagnostic
work-up and continuous monitoring of critically ill patients treated
at ICUs, which counteracts the complex clinical picture. In fact, a
large prospective study conducted by Combes et al. (2004) [30]
found a class I discrepancy rate of 10.2% in 1492 patients
admitted to the ICU, which matches our data on ICU cases in
2008 very well. In both studies, the autopsy rates for ICU patients
in the respective years were well above 50%. As already shown by
Combes and colleagues, our study mainly revealed that among the
class I discrepant cases, the majority of patients were immuno-
compromised and frequently had associated opportunistic infec-
tions. Less frequent examples for class I discrepancies in our cohort
are cases where clinical reasoning lead to the diagnosis septic shock
or shock of unknown origin but autopsy revealed a high grade
Non-Hodgkin lymphoma or a ruptured gastric ulcer as underlying
cause of the disease. As reviewed by De Vlieger et al. [31] there is
accumulating evidence matching our observations that the
discrepancy rates on ICUs can be attributed to a shift towards
infectious diseases with unusual clinical presentations that go along
with the advances in medical treatment (e.g. organ transplanta-
tion). Moreover, as briefly mentioned below, all sophisticated
diagnostic tools being used nowadays have limitations regarding
sensitivity and/or specificity. For example, Kirch and Schafii [17]
reported that CT scans and ultrasonography can yield false-
positive and false-negative diagnoses for 6% to 9% of patients.
Among other factors, these limitations may explain why pulmo-
nary embolism as well as infarction and thrombosis (heart,
mesenterium) are among the most often missed diagnoses in
ICU patients [30,31].
According to the current literature [3,16,17], the most often
missed diagnoses are myocardial infarction and pulmonary
embolism. In line with these data, our study shows cardiovascular
diseases to account for the main part of class I discrepancies for all
time points investigated.
We found significant declines of the class I discrepancy rates
with respect to cardiovascular, neoplastic and pulmonary diseases
as well as to internal medicine, and surgery. Indeed, all these
observations most likely reflect the improvement of clinical ante-
mortem diagnostics in the last decades. However, the class I
discrepancy rate in patients coming from neurological wards
nearly remained constant. Re-review of that special case group
showed that, exactly as in the overall calculation, cardiovascular
(e.g. myocardial infarction, pulmonary embolism) and neoplastic
diseases (e.g. metastasized carcinoma, malignant lymphoma) were
the most overseen diagnoses with relation to death.
In our opinion, an indifferent, or even dismissive attitude
towards autopsy service in general, either by pathologists or
clinicians is not conducive and ultimately counterproductive for
the progress of clinical and scientific knowledge and the health
care system in general [32,33]. As already discussed previously by
both clinicians and pathologists [2,19,34–37] there is a dual and
uncontentious role for autopsies as a benchmark and to unravel
diagnostic discrepancies, especially in times where economization
and cost-effectiveness are on the top of the agenda [4,38,39]. The
clinical non-forensic autopsy provides an economical and practical
knowledge source that directly aids the physician [18, study
initiated by the U.S. Department of Health and Human Services
2002], helps to describe novel diseases and is indispensable in
physician teaching and additionally adds important epidemiolog-
ical data to the mortality statistics [40] which often serve as a basis
for decisions in health policy with far-reaching consequences.
Furthermore, we are convinced, as other authors [3,16,18,19,24],
that closer consultations between clinicians and pathologists before
and after autopsy have already successfully reduced the diagnostic
discrepancy rate over time and should still do in future.
Even if performed with the highest quality standard, ante-
mortem diagnosis and clinical management have a multitude of
inherent limitations (e.g. resolution power of ultrasound devices),
which do influence clinical reasoning and decision making. This is
why we, although widely used, avoided the term ‘‘diagnostic
error’’ because an ‘‘error’’ interprets a diagnostic discrepancy
negatively suggesting an individual clinical approach as solely
causal for the discrepancy. The latter certainly affects discrepan-
cies but is by no means the only and single cause.
We believe that the rise and continuous refinement of diagnostic
tools and procedures as well as improving clinical management
and knowledge serendipitously led and will lead to a steadily
increasing number of patients whose diseases are recognized intra
vitam. However, some patients remain with a higher individual
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attention particularly to these [18,41].
Thus, we tried to draw up a clinical profile for patients who
have a high risk to receive a class I discrepancy. This may aid both
pathologists and clinicians to identify patients, who may potentially
benefit from exceptionally extensive and comprehensive diagnos-
tics intra vitam and helps to focus on these autopsies that are most
likely to uncover clinically relevant and death related but so far
unrecognized diagnoses post mortem.
A methodic difficulty is connected with the simultaneous
analysis of 67 subgroups for being at higher or lower risk for
class I discrepancies. In this context, we refrained from correcting
the p-values for multiple testing, because the sample size would be
too small for a reasonable powered test. The situation is similar to
subgroup analyses in clinical studies that are carried out without
multiple testing corrections and should be considered as explor-
ative [42].
Our risk-profile analysis visualized by heatmap-clustering
singled out patient groups that are at potentially higher or lower
risk for discrepant diagnoses. For instance, according to our data,
patients with infectious diseases treated at a LAICU in a
community hospital appear to have an increased risk for receiving
a class I discrepancy. Re-review of that special case group revealed
on the one hand overseen infections such as aspergillus and other
fungal pneumonia, HIV-associated pneumocystis pneumonia,
systemic nocardiosis or toxoplasmosis encephalitis, and on the
other hand cases with, for example, undiagnosed pulmonary
tuberculosis where sometimes disease-associated complications
and/or other non-detected diseases finally led to death. It may be
worthwhile to check whether similar data can be obtained from
other studies and finally corroborate these data from retrospective
studies in a prospective setting.
Interestingly, a comparison between the class I discrepancy rate
of East Berlin (in the former GDR) and West Berlin (FRG) in 1988
revealed no statistically significant differences indicating a
comparably high standard of clinical care at least in the Charite ´
University Hospital (East Berlin) and the Virchow University
Hospital of the Free University (West Berlin) on the verge of the
Berlin wall break down. This is particularly remarkable since the
autopsy rate at the Charite ´ University Hospital (96.6%, East
Berlin) was almost twice as high as in the Virchow University
Hospital (44.5%, West Berlin) in 1988 (two years prior to German
reunification).
Supporting Information
Figure S1 Class I discrepancy rates depending on the
clinical subspeciality of the ward.
(TIF)
Figure S2 Development of class I discrepancies in six
disease groups between 1988 and 2008. The discrepancy
rates were calculated by setting the number of cases with a class I
discrepancy into relation to all patients with a diagnosis in a
certain disease group. a) cardiovascular diseases (CV); b)
neoplastic diseases (NP); c) pulmonary diseases (PU); d)
gastrointestinal diseases (GI).
(TIF)
Figure S3 Development of class I discrepancies between
1988 and 2008 stratified by the cause of death. The
discrepancy rates were calculated by setting the number of cases
with a class I discrepancy into relation to all patients that died
from a certain disease group. a) cardiovascular diseases (CV); b)
neoplastic diseases (NP); c) pulmonary diseases (PU); d) gastroin-
testinal diseases (GI).
(TIF)
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